Human Organoids Market Size

Human Organoids Market size was valued at USD 2.83 billion in 2024 and is expected to reach USD 24.88 billion by 2037, expanding at around 18.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of human organoids is evaluated at USD 3.24 billion.

The growth of the market can be attributed to the rising incidence of infectious diseases, the growing need for organ transplants, along with the growing investment in the advancement of medical technologies, are expected to fuel the progress of the market. According to the U.S. Department Health Resources & Services Administration (HRSA) over 39,000 transplants were performed in 2020 in the US, while 17 people die each day waiting for an organ transplant.

In addition to these, factors that are believed to fuel the market growth of human organoids include the rising development of efficient tools and mechanisms for early diagnosis & treatment of infectious diseases that can facilitate more effective and rapid responses to medical conditions. Human organoids allow the creation of cellular models of clinical problems, such as infectious & genetic diseases, tumor modeling & bio-banking, gene function, and cell development, to further study them in the laboratory and develop accurate treatment methods. This is anticipated to be the major growth driver for the market. The growth of the market can also be attributed to the extensive medical research associated with drug discovery in western countries and the rising demand for advanced drugs. Human organoids may also be deployed for the customization of therapy or personalized medicine, which is also expected to contribute to the growth of the market.